Pansu Chumworathayi
Khon Kaen, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Associations of HLA and drug-metabolizing enzyme genes in co-trimoxazole-induced severe cutaneous adverse reactions.
Journal: Drug metabolism and pharmacokinetics
Published: May 11, 2022
Genetic variants associated with severe cutaneous adverse drug reactions induced by carbamazepine.
Journal: British journal of clinical pharmacology
Published: May 04, 2021
Genetic Association of Co-Trimoxazole-Induced Severe Cutaneous Adverse Reactions Is Phenotype-Specific: HLA Class I Genotypes and Haplotypes.
Journal: Clinical pharmacology and therapeutics
Published: December 10, 2019
Comparison between the HLA-B∗58 : 01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous Adverse Reactions.
Journal: Journal of immunology research
Published: July 24, 2017
Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population.
Journal: Pharmacogenetics and genomics
Published: May 17, 2017
Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population.
Journal: Pharmacogenetics and genomics
Published: March 02, 2016
Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions.
Journal: Pharmacogenetics and genomics
Published: June 19, 2015
Management for improving patients' knowledge and understanding about drug allergy.
Journal: Pharmacy practice
Published: September 15, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026